These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11100908)

  • 41. Alterations in dopamine clearance and catechol-O-methyltransferase activity by dopamine infusions in children.
    Allen E; Pettigrew A; Frank D; Thompson S; Myers C; Yamashita T; Blumer JL
    Crit Care Med; 1997 Jan; 25(1):181-9. PubMed ID: 8989196
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cardiac output is a determinant of the initial concentrations of propofol after short-infusion administration.
    Upton RN; Ludbrook GL; Grant C; Martinez AM
    Anesth Analg; 1999 Sep; 89(3):545-52. PubMed ID: 10475279
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prediction of the possibility of the secondary peaks of iv bolus drug plasma concentration time curve by the model that directly takes into account the transit time through the organ.
    Berezhkovskiy LM
    J Pharm Sci; 2009 Nov; 98(11):4376-90. PubMed ID: 19340884
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The influence of cardiac output distribution on the tissue/plasma drug concentration ratio.
    Fagiolino P
    Eur J Drug Metab Pharmacokinet; 2002; 27(2):79-81. PubMed ID: 12064375
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetic concepts - drug binding, apparent volume of distribution and clearance.
    Gibaldi M; Koup JR
    Eur J Clin Pharmacol; 1981; 20(4):299-305. PubMed ID: 7308282
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetic approach to the estimation of hepatic removal of insulin.
    Berzins R; Tam YK; Molnar GD; Rajotte RV; Wieczorek KR; McGregor JR; Fawcett DM
    Pancreas; 1986; 1(6):544-9. PubMed ID: 3550790
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pulmonary extraction and pharmacokinetics of prostaglandin E1 during continuous intravenous infusion in patients with adult respiratory distress syndrome.
    Cox JW; Andreadis NA; Bone RC; Maunder RJ; Pullen RH; Ursprung JJ; Vassar MJ
    Am Rev Respir Dis; 1988 Jan; 137(1):5-12. PubMed ID: 3337471
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Does regional norepinephrine spillover represent local sympathetic activity?
    Chang PC; Kriek E; van der Krogt JA; van Brummelen P
    Hypertension; 1991 Jul; 18(1):56-66. PubMed ID: 1860712
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Altered hepatic blood flow and drug disposition.
    Nies AS; Shand DG; Wilkinson GR
    Clin Pharmacokinet; 1976; 1(2):135-55. PubMed ID: 13954
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A new model-independent physiological approach to study hepatic drug clearance and its applications.
    Chiou WL
    Int J Clin Pharmacol Ther Toxicol; 1984 Nov; 22(11):577-90. PubMed ID: 6389376
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Drug availability to noneliminating tissues and sites of action following an intravenous dose.
    Cutler DJ
    J Pharm Sci; 1986 Dec; 75(12):1141-4. PubMed ID: 3559922
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Minaxolone, a new steroidal anesthetic. Pharmacokinetics and organ extraction in sheep.
    Gourlay GK; Mather LE; Parkin KS
    Drug Metab Dispos; 1980; 8(6):452-5. PubMed ID: 6109615
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Simple methods for estimation of mean residence time and steady-state volume of distribution from continuous-infusion data.
    Gillespie WR
    Pharm Res; 1991 Feb; 8(2):254-8. PubMed ID: 2023877
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The corrected traditional equations for calculation of hepatic clearance that account for the difference in drug ionization in extracellular and intracellular tissue water and the corresponding corrected PBPK equation.
    Berezhkovskiy LM
    J Pharm Sci; 2011 Mar; 100(3):1167-83. PubMed ID: 21355107
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Commentary: a physiological approach to hepatic drug clearance.
    Wilkinson GR; Shand DG
    Clin Pharmacol Ther; 1975 Oct; 18(4):377-90. PubMed ID: 1164821
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Hepatic elimination of thiopental in heart surgery patients].
    Lange H; Stephan H; Zielmann S; Brandt C; Sonntag H
    Anaesthesist; 1992 Apr; 41(4):171-8. PubMed ID: 1590573
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Steady-state volume of distribution and dilution factor.
    Bocchialini BM
    Arzneimittelforschung; 1994 Apr; 44(4):571-5. PubMed ID: 8011015
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Plasma clearance.
    Toutain PL; Bousquet-Mélou A
    J Vet Pharmacol Ther; 2004 Dec; 27(6):415-25. PubMed ID: 15601437
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Universally Unrecognized Assumption in Predicting Drug Clearance and Organ Extraction Ratio.
    Benet LZ; Liu S; Wolfe AR
    Clin Pharmacol Ther; 2018 Mar; 103(3):521-525. PubMed ID: 28762489
    [TBL] [Abstract][Full Text] [Related]  

  • 60. No effect of diltiazem on the hepatic clearance of indocyanine green in the rats.
    Joo EH; Lee YB
    Arch Pharm Res; 1998 Aug; 21(4):411-7. PubMed ID: 9875468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.